Fermenbio Balance Sheet Annual

Trade

BSE: 506414 | NSE: - | ISIN: INE225B01021 | Sector: Biotechnology & Drugs

370.75 +44.60 (13.67%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	59.83	0.13	1.13	3.29
Short Term Investments	0.88	25.28	20.40	27.63
Cashand Short Term Investments	60.71	60.52	33.45	44.43
Accounts Receivable- Trade Net	72.98	45.04	87.25	69.40
Total Receivables Net	77.64	56.44	95.94	80.52
Total Inventory	87.38	130.14	159.48	162.27
Other Current Assets Total	16.02	3.20	22.36	20.24
Total Current Assets	241.75	252.97	314.02	309.62
Property/ Plant/ Equipment Total- Net	253.47	258.47	237.33	219.41
Goodwill Net	4.12	11.53	10.95	10.71
Intangibles Net	7.16	13.27	17.60	21.01
Long Term Investments	9.83	45.81	73.07	69.11
Note Receivable- Long Term	8.45	12.87	17.75	16.55
Other Long Term Assets Total	23.05	40.88	36.13	40.67
Total Assets	547.83	635.81	706.84	687.08
Accounts Payable	64.90	45.79	64.58	62.14
Current Portof LT Debt/ Capital Leases	90.69	32.49	25.06	23.75
Other Currentliabilities Total	17.66	27.88	18.66	26.05
Total Current Liabilities	173.26	208.69	207.12	209.33
Long Term Debt	42.54	79.68	112.04	109.38
Capital Lease Obligations	5.54	5.90	4.61	2.76
Total Long Term Debt	48.07	85.58	116.65	112.14
Total Debt	138.77	219.52	239.18	232.19
Minority Interest	-3.70	-2.75	-0.68	-0.30
Other Liabilities Total	41.33	29.65	11.62	5.31
Total Liabilities	258.97	321.17	334.71	326.49
Common Stock Total	14.44	14.43	14.42	14.42
Retained Earnings( Accumulated Deficit)	274.42	287.78	342.26	334.26
Total Equity	288.86	314.63	372.13	360.59
Total Liabilities Shareholders' Equity	547.83	635.81	706.84	687.08
Total Common Shares Outstanding	2.89	2.89	2.88	2.88
Tangible Book Valueper Share Common Eq	96.14	100.44	119.10	114.00
Cash	-	35.12	11.92	13.50
Prepaid Expenses	-	2.68	2.79	2.17
Property/ Plant/ Equipment Total- Gross	-	340.47	303.96	267.83
Accumulated Depreciation Total	-	-82.01	-66.63	-48.41
Accrued Expenses	-	1.07	1.35	1.10
Notes Payable/ Short Term Debt	-	101.46	97.48	96.30
Additional Paid- In Capital	-	13.25	14.69	12.00
Other Equity Total	-	-0.83	0.76	-0.09